Page 74 - AN-3-2

Advanced Neurology Inflammation in diabetic stroke: Treatment target

of microglia toward M2 phenotype via the TLR4 pathway. 88. Xu J, Wang A, Meng X, et al. Edaravone dexborneol versus
Life Sci. 2019;237:116915. edaravone alone for the treatment of acute ischemic stroke:
A phase III, randomized, double-blind, comparative trial.
doi: 10.1016/j.lfs.2019.116915
Stroke. 2021;52(3):772-780.
78. Amantea D, Petrelli F, Greco R, et al. Azithromycin affords
neuroprotection in rat undergone transient focal cerebral doi: 10.1161/STROKEAHA.120.031197
ischemia. Front Neurosci. 2019;13:1256. 89. Shuaib A, Lees KR, Lyden P, et al. NXY-059 for the treatment
of acute ischemic stroke. N Engl J Med. 2007;357(6):562-571.
doi: 10.3389/fnins.2019.01256
doi: 10.1056/NEJMoa070240
79. Hernandez-Jimenez M, Abad-Santos F, Cotgreave I, et al.
Safety and efficacy of ApTOLL in patients with ischemic 90. Kobayashi S, Fukuma S, Ikenoue T, Fukuhara S,
stroke undergoing endovascular treatment: A phase 1/2 Kobayashi S. Effect of edaravone on neurological symptoms
randomized clinical trial. JAMA Neurol. 2023;80(8):779-788. in real-world patients with acute ischemic stroke. Stroke.
2019;50(7):1805-1811.
doi: 10.1001/jamaneurol.2023.1660
doi: 10.1161/STROKEAHA.118.024351
80. Wei N, Yu SP, Gu XH, et al. The involvement of autophagy
pathway in exaggerated ischemic brain damage in diabetic 91. Ji J, Zhang R, Li H, Zhu J, Pan Y, Guo Q. Analgesic and anti-
mice. CNS Neurosci Ther. 2013;19(10):753-763. inflammatory effects and mechanism of action of borneol on
photodynamic therapy of acne. Environ Toxicol Pharmacol.
doi: 10.1111/cns.12123 2020;75:103329.
81. D’Souza B, D’Souza V, Sowmya S, et al. A comparative study doi: 10.1016/j.etap.2020.103329
on oxidative stress and antioxidant status in ischemic stroke
patients with and without diabetes. Indian J Clin Biochem. 92. Zhao L, Hu FX. α-Lipoic acid treatment of aged type 2
2008;23(3):218-222. diabetes mellitus complicated with acute cerebral infarction.
Eur Rev Med Pharmacol Sci. 2014;18(23):3715-3719.
doi: 10.1007/s12291-008-0049-8
93. Tan DX, Manchester LC, Qin L, Reiter RJ. Melatonin:
82. Bemeur C, Ste-Marie L, Montgomery J. Increased oxidative A mitochondrial targeting molecule involving mitochondrial
stress during hyperglycemic cerebral ischemia. Neurochem protection and dynamics. Int J Mol Sci. 2016;17(12):2124.
Int. 2007;50(7-8):890-904.
doi: 10.3390/ijms17122124
doi: 10.1016/j.neuint.2007.03.002
94. Xu Q, Cheung RTF. Melatonin mitigates type 1 diabetes-
83. Soloniuk DS, Perkins E, Wilson JR. Use of allopurinol and aggravated cerebral ischemia-reperfusion injury through
deferoxamine in cellular protection during ischemia. Surg anti-inflammatory and anti-apoptotic effects. Brain Behav.
Neurol. 1992;38(2):110-113. 2023;13(9):e3118.
doi: 10.1016/0090-3019(92)90087-4 doi: 10.1002/brb3.3118
84. Sugimoto K, Iadecola C. Delayed effect of administration of 95. Yu W, Ren C, Ji X. A review of remote ischemic conditioning
COX-2 inhibitor in mice with acute cerebral ischemia. Brain as a potential strategy for neural repair poststroke. CNS
Res. 2003;960(1-2):273-276. Neurosci Ther. 2023;29(2):516-524.
doi: 10.1016/s0006-8993(02)03805-2 doi: 10.1111/cns.14064
85. Dawson J, Quinn T, Harrow C, et al. Allopurinol and 96. Liu C, Zhang C, Du H, Geng X, Zhao H. Remote ischemic
nitric oxide activity in the cerebral circulation of those preconditioning protects against ischemic stroke in
with diabetes: A randomized trial. Diabetes Care. streptozotocin-induced diabetic mice via anti-inflammatory
2009;32(1):135-137. response and anti-apoptosis. Brain Res. 2019;1724:146429.
doi: 10.2337/dc08-1179 doi: 10.1016/j.brainres.2019.146429
86. Dawson J, Robertson M, Dickie DA, et al. Xanthine oxidase 97. Kan X, Yan Z, Wang F, et al. Efficacy and safety of
inhibition and white matter hyperintensity progression remote ischemic conditioning for acute ischemic stroke:
following ischaemic stroke and transient ischaemic attack A comprehensive meta-analysis from randomized controlled
(XILO-FIST): A multicentre, double-blinded, randomised, trials. CNS Neurosci Ther. 2023;29(9):2445-2456.
placebo-controlled trial. EClinicalMedicine. 2023;57:101863.
doi: 10.1111/cns.14240
doi: 10.1016/j.eclinm.2023.101863
98. Zhao W, Hausenloy DJ, Hess DC, Yellon DM, Ji X. Remote
87. Lees KR, Zivin JA, Ashwood T, et al. NXY-059 for acute ischemic conditioning: Challenges and opportunities.
ischemic stroke. N Engl J Med. 2006;354(6):588-600. Stroke. 2023;54(8):2204-2207.
doi: 10.1056/NEJMoa052980 doi: 10.1161/STROKEAHA.123.043279

Volume 3 Issue 2 (2024) 13 doi: 10.36922/an.1694